Impact of pulmonary exacerbations and lung function on generic health-related quality of life in patients with cystic fibrosis

BACKGROUND: The analysis aimed to examine the impact of pulmonary exacerbations (PEs) and lung function on generic measures of HRQL in patients with cystic fibrosis (CF) using trial-based data. METHODS: In a 48-week randomized, placebo-controlled study of ivacaftor in patients ≥12 years with CF and...

Descripción completa

Detalles Bibliográficos
Autores principales: Solem, Caitlyn T., Vera-Llonch, Montserrat, Liu, Sizhu, Botteman, Marc, Castiglione, Brenda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839094/
https://www.ncbi.nlm.nih.gov/pubmed/27097977
http://dx.doi.org/10.1186/s12955-016-0465-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839094/
https://www.ncbi.nlm.nih.gov/pubmed/27097977
http://dx.doi.org/10.1186/s12955-016-0465-z

Ejemplares similares